K. Wendelin

发表

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.

K. Kreuzer, A. Hüttmann, H. Serve, 2012, Blood.

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

E. Holler, G. Kobbe, S. Schönland, 2022, Transplantation and cellular therapy.

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

A. Ho, C. Junghanss, G. Ehninger, 2012, The Lancet.

First Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 705 Adults with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL/LBL)

K. Spiekermann, F. Schneller, H. Serve, 2021, Blood.

A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantat

G. Ehninger, M. Schaich, M. Schubert, 2008 .

Evaluation of Minimal Residual Disease (MRD) and MRD-Based Treatment Decisions in Ph/BCR-ABL Negative Adult Acute Lymphoblastic Leukemia (ALL): Experience from the German Multicenter Study Group for Adult ALL (GMALL)

C. Lutz, H. Serve, R. Wäsch, 2017 .

Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

J. Cayuela, H. Dombret, K. Spiekermann, 2018, Blood.

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

E. Buss, H. Serve, I. Schmidt-Wolf, 2012 .

Spontaneous remission of acute lymphoblastic leukemia: A case report

K. Schaefer-Eckart, K. Wendelin, Timm Höres, 2017, Oncology letters.

Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma

C. Haferlach, H. Serve, Sebastian E. Koschade, 2019, Annals of Hematology.

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

T. Lipp, E. Thiel, N. Kröger, 2009 .

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

M. Spielmann, K. Döhner, H. Busch, 2022, Leukemia.

Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL / T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL

F. Schneller, H. Serve, W. Fiedler, 2022, Blood.

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia

S. Raffel, A. Elmaagacli, K. Kreuzer, 2023, Haematologica.

Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).

M. Schaich, H. Wandt, M. Wilhelm, 2006 .

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

C. Kiewitz, F. Oduncu, M. Kull, 2024, Frontiers in Hematology.